Dr. Sid Pharmaceutical Private Limited
About Dr. Sid Pharmaceutical Private Limited
Data last updated:
Dr. Sid Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U85200RJ2020PTC068993. Its GSTIN is 08AAHCD7656F1ZE (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manohar Lal Chhabra and Anita Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No. E – 2 Office No.405 Armrapali Plaza, Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.39 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -3.1%) and EBITDA of ₹4.07 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 168% over three years.
Court records list 15 cases involving the company, including 15 filed by the company; 7 cases are pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP.No. E – 2 Office No.405 Armrapali Plaza, Jaipur, Rajasthan, India – 302021
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dr. Sid Pharmaceutical Private Limited
The main business activity of Dr. Sid Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dr. Sid Pharmaceutical Private Limited FY 2025 filings available
Dr. Sid Pharmaceutical Private Limited reported revenue of ₹1.39 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Dr. Sid Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 168% over three years, including 17% growth in the latest year. EBITDA rose 146% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dr. Sid Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.07 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.33 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Dr. Sid Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• |
| Net Profit Margin | -3.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dr. Sid Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Its own revenue is ₹1.39 Cr.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Quest Biotech (India) Private Limited | ₹1.4 Cr | ₹1.25 Lakh | 1% | -3% | Lucknow, Uttar Pradesh, India | |
| Humanix Lifesciences Private Limited | ₹1.4 Cr | ₹1.02 Cr | 73% | +113% | Delhi, India | |
| Ziness Healthcare (OPC) Private Limited | ₹1.4 Cr | ₹9.34 Lakh | 7% | +71% | Faridabad, Haryana, India | |
| Samrudh Healthcare Private Limited | ₹1.39 Cr | ₹25.34 Lakh | 18% | +4% | Mumbai, Maharashtra, India | |
| Torway Pharmacia Private Limited | ₹1.39 Cr | ₹67,073 | 0% | -28% | 1 | New, Delhi, India |
| Dr. Sid Pharmaceutical Private Limited this company | ₹1.39 Cr | ₹4.33 Lakh | -3.1% | Jaipur, Rajasthan, India | ||
| Rhythm Pharma India Private Limited | ₹1.39 Cr | ₹21.81 Lakh | -16% | -28% | Salem, Tamil Nadu, India | |
| Clyde Biotech Private Limited | ₹1.39 Cr | ₹9.77 Lakh | -7% | -2% | Patna, Bihar, India | |
| Satyam Drugs Private Limited | ₹1.39 Cr | ₹35,832 | 0% | -71% | New, Delhi, India | |
| Yuaasa Healthcare Private Limited | ₹1.39 Cr | ₹12.61 Lakh | -9% | +24% | Thane, Maharashtra, India | |
| Miral Health Care Private Limited | ₹1.39 Cr | ₹1.11 Lakh | 1% | -4% | 16 | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Dr. Sid Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.
Auditor Details of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited is audited by AVINASH K GUPTA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AVINASH K GUPTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manohar Lal Chhabra Also directs: Dr.Sid Laboratories LLP, TPPL Pharmaceuticals Private Limited | Director | 06 Jun 2020 | 6 Years 4 Months | Current |
| Anita Chhabra | Director | 02 Feb 2023 | 3 Years 8 Months | Current |
Ownership and Shareholding of Dr. Sid Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited has 15 court cases on record: 15 filed by Dr. Sid Pharmaceutical. 7 cases are pending and 8 are disposed. Status as checked between 03 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 0 | 7 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Court case (CMCC) | Filed by the company against Registrar of Trade Marks | Pending |
| High Court of Rajasthan | Court case (CSTAY) | Filed by the company against Registrar of Trade Marks | Pending |
| High Court of Rajasthan | Appeal | Filed by the company against Registrar of Trade Marks | Pending |
| High Court of Rajasthan | Court case (CSTAY) | Filed by the company against Registrar of Trade Mark | Pending |
| High Court of Rajasthan | Appeal | Filed by the company against Registrar of Trade Mark | Pending |
Full case history
All 15 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited has a workforce of 0 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Rajendra Prsad Nehara ceased to be Director on 31 Jul 2025.
Credit Ratings, Litigation & Regulatory Alerts for Dr. Sid Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dr. Sid Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dr. Sid Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCD7656F1ZE | Rajasthan | Active | 31 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dr. Sid Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dr. Sid Pharmaceutical Private Limited
Dr. Sid Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2020 (6+ years old) and is registered under CIN U85200RJ2020PTC068993.
Dr. Sid Pharmaceutical reported revenue of ₹1.39 Cr for FY 2024 (up 17% YoY).
Dr. Sid Pharmaceutical has 2 current directors:
- Manohar Lal Chhabra - Director
- Anita Chhabra - Director
Dr. Sid Pharmaceutical reported a net loss of ₹4.33 Lakh (net margin -3.1%) and EBITDA of ₹4.07 Lakh (EBITDA margin 2.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dr. Sid Pharmaceutical is 168% over three years. In the latest year (FY 2024) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dr. Sid Pharmaceutical is 08AAHCD7656F1ZE, registered in Rajasthan.
The CIN (Corporate Identification Number) of Dr. Sid Pharmaceutical is U85200RJ2020PTC068993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Sid Pharmaceutical has 15 court cases on record: 15 filed by the company. 7 are pending.
Dr. Sid Pharmaceutical was incorporated on 06 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Dr. Sid Pharmaceutical by revenue are Quest Biotech (India) Private Limited, Humanix Lifesciences Private Limited, Ziness Healthcare (OPC) Private Limited, Samrudh Healthcare Private Limited, Torway Pharmacia Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rajendra Prsad Nehara ceased to be Director on 31 Jul 2025. Anita Chhabra was appointed as Director on 02 Feb 2023. Anita Chhabra ceased to be Director on 25 Feb 2022. Dr. Sid Pharmaceutical has 4 board changes on record in total.